| Style | Citing Format |
|---|---|
| MLA | Joghataie P, et al.. "Nickel-Induced Cardiotoxicity: Immunopathogenesis, Thromboinflammation, and a Targeted Nanotherapeutic Strategy." International Immunopharmacology, vol. 170, no. , 2026, pp. -. |
| APA | Joghataie P, Habibi Z, Bahrampour A, Danjeh M, Molaee P, Yousefi Chermehini N, Forouzin S, Zamanifard S, Nikdoust F (2026). Nickel-Induced Cardiotoxicity: Immunopathogenesis, Thromboinflammation, and a Targeted Nanotherapeutic Strategy. International Immunopharmacology, 170(), -. |
| Chicago | Joghataie P, Habibi Z, Bahrampour A, Danjeh M, Molaee P, Yousefi Chermehini N, Forouzin S, Zamanifard S, Nikdoust F. "Nickel-Induced Cardiotoxicity: Immunopathogenesis, Thromboinflammation, and a Targeted Nanotherapeutic Strategy." International Immunopharmacology 170, no. (2026): -. |
| Harvard | Joghataie P et al. (2026) 'Nickel-Induced Cardiotoxicity: Immunopathogenesis, Thromboinflammation, and a Targeted Nanotherapeutic Strategy', International Immunopharmacology, 170(), pp. -. |
| Vancouver | Joghataie P, Habibi Z, Bahrampour A, Danjeh M, Molaee P, Yousefi Chermehini N, et al.. Nickel-Induced Cardiotoxicity: Immunopathogenesis, Thromboinflammation, and a Targeted Nanotherapeutic Strategy. International Immunopharmacology. 2026;170():-. |
| BibTex | @article{ author = {Joghataie P and Habibi Z and Bahrampour A and Danjeh M and Molaee P and Yousefi Chermehini N and Forouzin S and Zamanifard S and Nikdoust F}, title = {Nickel-Induced Cardiotoxicity: Immunopathogenesis, Thromboinflammation, and a Targeted Nanotherapeutic Strategy}, journal = {International Immunopharmacology}, volume = {170}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Joghataie P AU - Habibi Z AU - Bahrampour A AU - Danjeh M AU - Molaee P AU - Yousefi Chermehini N AU - Forouzin S AU - Zamanifard S AU - Nikdoust F TI - Nickel-Induced Cardiotoxicity: Immunopathogenesis, Thromboinflammation, and a Targeted Nanotherapeutic Strategy JO - International Immunopharmacology VL - 170 IS - SP - EP - PY - 2026 ER - |